More Chantix Suicides Reported
Thursday, November 20th, 2008November 11th, 2008 – The British Government has released data confirming that, like the United States, users of Champix, the European version of the stop-smoking drug known as Chantix in the United States, have been reporting a number of adverse reactions associated with the drug, including suicides and suicidal thoughts.
Chantix and Champix, which are both manufactured by Pfizer, Inc., contain the pharmaceutical ingredient varenicline tartrate, which blocks brain receptors that are normally stimulated by nicotine. The drug is designed to lessen the pleasure effects of nicotine and help users quit smoking.
In the United States, Chantix has been associated with a number of serious and potentially life-threatening side effects, including an increased risk of suicide, suicide attempts and unusual behavior. A number of users have also report developing new-onset diabetes after taking the drug and suffering seizures and blackouts, which could result in serious accidents or injury.